Peter G. Traber,Eliezer Zomer,Deirdre Slate,Joseph M. Johnson,Ryan George,Sharon Shechter,Raphael Nir
申请号：
US16611620
公开号：
US20200061095A1
申请日:
2018.05.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Aspects of the invention relate to novel synthetic compounds for treatment of metabolic diseases partially associated with systemic insulin resistance caused by Galectin proteins binding and inhibiting insulin and TGFb1 receptors causing physiological disturbances in the insulin pathways.
